ADMA Biologics, Inc. To Present At 9th Annual JMP Securities Healthcare Conference On June 24
6/16/2014 8:57:16 AM
ADMA Biologics, Inc. (OTCQB: ADMA), a late stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced that Adam Grossman, ADMA’s President, Chief Executive Officer and founder, is scheduled to present a company overview at the conference on Tuesday, June 24, 2014 at 12:00 p.m. EDT, at The Westin New York Grand Central Hotel, New York, NY.
Help employers find you! Check out all the jobs and post your resume.
comments powered by